Choosing wisely - when to mend a broken heart with ECMO?

Critical Care

Volumn 18, Issue 1, 2014, Pages

  Stephens, R Scott ^a   Fan, Eddy ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE;

BLOOD; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SURGERY; EXTRACORPOREAL OXYGENATION; FEMALE; HUMAN; MALE; MORTALITY; PROCEDURES;

BUTYRYLCHOLINESTERASE; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SURGICAL PROCEDURES; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HUMANS; MALE;

EID: 84894261906     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13736     Document Type: Note

References (14)

1. Distelmaier K, Winter MP, Rützler K, Heinz G, Lang IM, Maurer G, Koinig H, Steinlechner B, Niessner A, Goliasch G. Serum butyrylcholinesterase predicts survival following extracorporeal membrane oxygenation after cardiovascular surgery. Crit Care 2014, 18:R24. 10.1186/cc13711, 24479557.
2. Rastan AJ, Dege A, Mohr M, Doll N, Falk V, Walther T, Mohr FW. Early and late outcomes of 517 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock. J Thorac Cardiovasc Surg 2010, 139:302-311. 10.1016/j.jtcvs.2009.10.043, 20106393.
3. Bartlett RH, Roloff DW, Custer JR, Younger JG, Hirschl RB. Extracorporeal life support: the University of Michigan experience. JAMA 2000, 283:904-908. 10.1001/jama.283.7.904, 10685715.
4. Fiser SM, Tribble CG, Kaza AK, Long SM, Zacour RK, Kern JA, Kron IL. When to discontinue extracorporeal membrane oxygenation for postcardiotomy support. Ann Thorac Surg 2001, 71:210-214. 10.1016/S0003-4975(00)02340-7, 11216748.
5. Smedira NG, Moazami N, Golding CM, McCarthy PM, Apperson-Hansen C, Blackstone EH, Cosgrove DM. Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years. J Thorac Cardiovasc Surg 2001, 122:92-102. 10.1067/mtc.2001.114351, 11436041.
6. Smedira NG, Blackstone EH. Postcardiotomy mechanical support: risk factors and outcomes. Ann Thorac Surg 2001, 71:S60-S66. 10.1016/S0003-4975(00)02626-6, 11265868.
7. Aissaoui N, Luyt CE, Leprince P, Trouillet JL, Léger P, Pavie A, Diebold B, Chastre J, Combes A. Predictors of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock. Intensive Care Med 2011, 37:1738-1745. 10.1007/s00134-011-2358-2, 21965097.
8. Distelmaier K, Niessner A, Haider D, Lang IM, Heinz G, Maurer G, Koinig H, Steinlechner B, Goliasch G. Long-term mortality in patients with chronic obstructive pulmonary disease following extracorporeal membrane oxygenation for cardiac assist after cardiovascular surgery. Intensive Care Med 2013, 39:1444-1451. 10.1007/s00134-013-2931-y, 23612760.
9. Luyt CE, Landivier A, Leprince P, Bernard M, Pavie A, Chastre J, Combes A. Usefulness of cardiac biomarkers to predict cardiac recovery in patients on extracorporeal membrane oxygenation support for refractory cardiogenic shock. J Crit Care 2012, 27:524-514.
10. Goliasch G, Haschemi A, Marculescu R, Endler G, Maurer G, Wagner O, Huber K, Mannhalter C, Niessner A. Butyrylcholinesterase activity predicts long-term survival in patients with coronary artery disease. Clin Chem 2012, 58:1055-1058. 10.1373/clinchem.2011.175984, 22294734.
11. Stojanov MD, Jovicic DM, Djuric SP, Konjevic MM, Todorovic ZM, Prostran MS. Butyrylcholinesterase activity and mortality risk in hemodialysis patients: comparison to hsCRP and albumin. Clin Biochem 2009, 42:22-26. 10.1016/j.clinbiochem.2008.10.010, 19010318.
12. Calderon-Margalit R, Adler B, Abramson JH, Gofin J, Kark JD. Butyrylcholinesterase activity, cardiovascular risk factors, and mortality in middle-aged and elderly men and women in Jerusalem. Clin Chem 2006, 52:845-852. 10.1373/clinchem.2005.059857, 16527886.
13. Ben Assayag E, Shenhar-Tsarfaty S, Ofek K, Soreq L, Bova I, Shopin L, Berg RM, Berliner S, Shapira I, Bornstein NM, Soreq H. Serum cholinesterase activities distinguish between stroke patients and controls and predict 12-month mortality. Mol Med 2010, 16:278-286. 2896466, 20464061.
14. Schmidt M, Zogheib E, Rozé H, Repesse X, Lebreton G, Luyt CE, Trouillet JL, Bréchot N, Nieszkowska A, Dupont H, Ouattara A, Leprince P, Chastre J, Combes A. The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Intensive Care Med 2013, 39:1704-1713. 10.1007/s00134-013-3037-2, 23907497.